Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.23.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
9.
Stock-Based Compensation

2020 Equity Incentive Plan

The Company’s 2020 Plan was established for granting stock incentive awards to directors, officers, employees and consultants to the Company.

 

Stock Options

During the six months ended June 30, 2023, the Company granted 86,669 options with a weighted average strike price of $4.28 to purchase common stock to certain employees and the Board of Directors. Employee options vest annually in 3 equal parts over 3 years, whilst Board of Directors options vest over 1 year. The Company granted 25,000 performance-based options with a weighted average strike price of $4.44 to purchase common stock to certain employees. These options are subject to performance vesting and will vest and become exercisable once the performance conditions have been met. There is no assurance that the performance conditions will be met and therefore some or all of these options may never vest or become exercisable. The total aggregate grant date fair value of all options granted was $338,741.

During the six months ended June 30, 2022, the Company granted 66,648 options with a weighted average strike price of $5.80 to purchase common stock to certain employees and the Board of Directors. Employee options vest annually in 3 equal parts over 3 years, whilst Board of Directors options vest over 1 year. The Company granted 62,500 performance-based options with a weighted average strike price of $6.02 to purchase common stock to certain employees. These options are subject to performance vesting and will vest and become exercisable once the performance conditions have been met. There is no assurance that the performance conditions will be met and therefore some or all of these options may never vest or become exercisable. The total aggregate grant date fair value of all options granted was $505,649.

During the three and six months ended June 30, 2023 and 2022 no defined performance conditions were probable of being met.

Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:

 

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development

 

$

40,259

 

 

$

41,592

 

 

$

78,876

 

 

$

63,005

 

Selling, general and administrative

 

 

84,586

 

 

 

91,175

 

 

 

169,242

 

 

 

192,991

 

Total stock-based compensation expense

 

$

124,845

 

 

$

132,767

 

 

$

248,118

 

 

$

255,996